Papotti et al. (2002) |
|
- |
negative |
+ |
< 25% of tumor cells positive |
++ |
25%-50% of tumor cells positive |
+++ |
> 50% of tumor cells positive |
|
Volante et al. (2007) |
– only for SSTR2A |
0 |
no immunoreactivity |
1 |
only cytoplasmatic immunoreaction, focal or diffuse |
2 |
membrane immunoreaction < 50% |
3 |
membrane immunoreaction > 50% |
|
Volante et al. (2007) |
- for SSTR 3 and 5 |
positive |
> 10% cytoplasmatic staining |
|
Corleto et al. (2009) |
|
0 |
no staining |
+ |
mildly positive |
++ |
moderately positive |
+++ |
intensely positive |
|
Miederer et al. (2009) |
- for SSTR2A |
0 |
negative |
1+ |
mild incomplete membrane reaction |
2+ |
moderate complete membrane reaction |
3+ |
strong complete membrane reaction |
|
Zamora et al. (2010) |
|
Negative |
no receptor expression |
focally positive |
< 25% of positive cells with heterogenous pattern |
positive |
> 25% of positive cells with moderate to strong density |